Captivate Bio and EverCell Bio are excited to announce a new collaboration to accelerate the development of pluripotent stem cell derived technologies. Built on the strengths of both companies, this collaboration brings together stem cell services paired with customer-defined media and reagents to accelerate discovery in regenerative medicine.
EverCell Bio’s service platform can accommodate everything from reprogramming, gene modification, and differentiation to cell expansion and cell banking. Now coupled with Captivate Bio’s product portfolio and reagent sourcing services, we focus on building the tools so you can focus on discovery.
EverCell Bio offers reprogramming services using a variety of methods and technologies, including episomal, viral, and RNA. The EverCell Bio team has the expertise, protocols, and resources to reprogram and deliver specialized cell lines derived in your preferred culture system.
Differentiation services address small- or large-scale production needs, including differentiation into neuronal, hepatic, and cardiac cell types, client-provided protocols can also be supported. Dedicated stem cell specialists will provide ongoing support for your disease modeling studies.
Whether you’re looking to generate a specific cell type or need to adapt a cell type to a new protocol – EverCell Bio’s team of stem cell experts will generate high-quality, fully characterized cell lines, tailored for use as physiologically relevant cell line models.
A number of optimized protocols for differentiating iPSCs into neural lineages, including neural progenitor cells, cortical, and motor neurons. EverCell’s practical and modular milestone approach, allows for customized delivery of cells, including executing our Client protocols, to ensure an efficient and successful result for each project.
EverCell Bio has developed several cardiac production workflows for drug discovery including customizable generation of cardiomyocytes from hiPSCs. With the ability to produce cardiomyocytes in a variety of culture formats at small- or large-scale, EverCell Bio’s expertise and adaptable approach smoothly integrates differentiation services into any discovery program, generating reliable models so you can focus on discovery.
We have developed an automated workflow for single cell subcloning of hiPSCs for applications including cell line generation, gene editing, and more. By investing heavily in technology that enhances scalability and quality at any stage of cell line development, our services are streamlined to accommodate the inherent variability of iPSCs, while maintaining reproducibility and scalability in your cell production.
Emerging technologies including gene and cell therapy research needs are quickly evolving, and often key components are difficult to find. Captivate Bio’s custom sourcing service quickly delivers serum, basal media, small molecules, and recombinant proteins that will deliver the results you need.
